
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-13 | Strobeck Matthew | Director | Purchase | 10.0K | $23.96 | $240K | 27.8K | View ↗ | |
| 2026-02-13 | 2026-02-13 | Busky Joseph M. | Chief Financial Officer | Purchase | 3,370 | $23.66 | $80K | 10.3K | View ↗ | |
| 2026-02-13 | 2026-02-13 | Blaser Brian J. | President and CEO | Purchase | 10.5K | $23.59 | $249K | 40.1K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total revenues | $2.73B-1.9% | $2.78B-7.2% | $3.00B-8.2% | $3.27B+92.3% | $1.70B |
| Cost of sales, excluding amortization of intangibles | $1.46B-2.7% | $1.50B-0.3% | $1.50B+12.9% | $1.33B+216.4% | $420.3M |
| Selling, marketing and administrative | $746.3M-2.7% | $766.8M+0.5% | $763.2M+22.9% | $621.0M+159.2% | $239.6M |
| Research and development | $186.2M-14.9% | $218.7M-10.7% | $245.0M+30.4% | $187.9M+96.3% | $95.7M |
| Amortization of intangible assets | $189.2M-7.0% | $203.4M-0.7% | $204.8M+54.6% | $132.5M+383.6% | $27.4M |
| Restructuring, integration and other charges | $263.6M+107.2% | $127.2M+12.2% | $113.4M | — | — |
| Goodwill impairment charge | $700.7M-61.6% | $1.82B | $0 | $0 | — |
| Asset impairment charge | $9.7M-83.0% | $56.9M+1164.4% | $4.5M+60.7% | $2.8M | — |
| Other operating expenses | $97.7M+88.6% | $51.8M+91.1% | $27.1M+120.3% | $12.3M | $0 |
| Operating (loss) income | -$919.2M+53.1% | -$1.96B-1509.7% | $139.1M-83.5% | $843.7M | — |
| Interest expense, net | $177.6M+8.6% | $163.5M+10.8% | $147.6M+95.0% | $75.7M+1205.2% | $5.8M |
| Loss on extinguishment of debt | $5.1M | $0 | $0-100.0% | $24.0M | $0 |
| Other expense, net | $5.8M-18.3% | $7.1M-65.5% | $20.6M+154.3% | $8.1M | — |
| Loss before income taxes | -$1.11B+48.0% | -$2.13B-7224.7% | -$29.1M | — | — |
| Provision for (benefit from) income taxes | $24.1M+130.3% | -$79.5M-318.4% | -$19.0M | — | — |
| Net loss | -$1.13B+44.8% | -$2.05B-20216.8% | -$10.1M | — | — |
| Basic loss per share | -$16.7M+45.4% | -$30.5M-20260.0% | -$150K | — | — |
| Diluted loss per share | -$16.7M+45.4% | -$30.5M-20260.0% | -$150K | — | — |
| Weighted-average shares outstanding - basic | $67.8M+0.9% | $67.2M+0.6% | $66.8M+17.6% | $56.8M+34.9% | $42.1M |
| Weighted-average shares outstanding - diluted | $67.8M+0.9% | $67.2M+0.6% | $66.8M+16.4% | $57.4M+33.8% | $42.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
QuidelOrtho Corporation 2026 Q1 - Results - Earnings Call Presentation
Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
QuidelOrtho forecasts $2.7B-$2.75B 2026 revenue while targeting $100M-$120M free cash flow amid China pricing uncertainty